| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-04-28 12:53:25 UTC |
|---|
| Updated at | 2022-04-28 12:53:25 UTC |
|---|
| NP-MRD ID | NP0068015 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Ervatamine |
|---|
| Description | Ervatamine belongs to the class of organic compounds known as ervatamia alkaloids. These are alkaloids with a structure based on the tetracyclic ervatamia skeleton, which arises from the 5,6- bond cleavage and 6,16- bond formation in the vobasine skeleton. Ervatamine is found in Ervatamia divaricata, Ervatamia orientalis , Tabernaemontana corymbosa, Tabernaemontana orientalis R.Br. and Tabernaemontana pandacaqui. Ervatamine was first documented in 2015 (PMID: 25435251). Based on a literature review a small amount of articles have been published on Ervatamine (PMID: 30987224) (PMID: 34001508) (PMID: 27077800) (PMID: 26024020). |
|---|
| Structure | CC[C@@H]1CN(C)C[C@]2(CC3=C(NC4=CC=CC=C34)C(=O)C[C@@H]12)C(=O)OC InChI=1S/C21H26N2O3/c1-4-13-11-23(2)12-21(20(25)26-3)10-15-14-7-5-6-8-17(14)22-19(15)18(24)9-16(13)21/h5-8,13,16,22H,4,9-12H2,1-3H3/t13-,16+,21+/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Epiervatamine | MeSH | | Ervatamine alkaloid | MeSH | | Ervatamine monohydrochloride | MeSH | | Ervatamine, 4R-(4alpha,4abeta,12abeta) isomer | MeSH |
|
|---|
| Chemical Formula | C21H26N2O3 |
|---|
| Average Mass | 354.4500 Da |
|---|
| Monoisotopic Mass | 354.19434 Da |
|---|
| IUPAC Name | methyl (3R,7S,8S)-7-ethyl-5-methyl-10-oxo-5,12-diazatetracyclo[9.7.0.0^{3,8}.0^{13,18}]octadeca-1(11),13,15,17-tetraene-3-carboxylate |
|---|
| Traditional Name | methyl (3R,7S,8S)-7-ethyl-5-methyl-10-oxo-5,12-diazatetracyclo[9.7.0.0^{3,8}.0^{13,18}]octadeca-1(11),13,15,17-tetraene-3-carboxylate |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC[C@@H]1CN(C)C[C@]2(CC3=C(NC4=CC=CC=C34)C(=O)C[C@@H]12)C(=O)OC |
|---|
| InChI Identifier | InChI=1S/C21H26N2O3/c1-4-13-11-23(2)12-21(20(25)26-3)10-15-14-7-5-6-8-17(14)22-19(15)18(24)9-16(13)21/h5-8,13,16,22H,4,9-12H2,1-3H3/t13-,16+,21+/m1/s1 |
|---|
| InChI Key | METLQVFFFUYXNT-QTPGKHNVSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as ervatamia alkaloids. These are alkaloids with a structure based on the tetracyclic ervatamia skeleton, which arises from the 5,6- bond cleavage and 6,16- bond formation in the vobasine skeleton. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Alkaloids and derivatives |
|---|
| Class | Ervatamia alkaloids |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Ervatamia alkaloids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Ervatamia skeleton
- 3-alkylindole
- Indole
- Indole or derivatives
- Piperidinecarboxylic acid
- Aryl alkyl ketone
- Aryl ketone
- Aralkylamine
- Piperidine
- Benzenoid
- Pyrrole
- Heteroaromatic compound
- Methyl ester
- Amino acid or derivatives
- Carboxylic acid ester
- Ketone
- Tertiary amine
- Tertiary aliphatic amine
- Monocarboxylic acid or derivatives
- Carboxylic acid derivative
- Azacycle
- Organoheterocyclic compound
- Organic oxide
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Amine
- Hydrocarbon derivative
- Carbonyl group
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Zhou J, Du SY, Dong HJ, Fang L, Feng JH: Preparative Separation of Monoterpenoid Indole Alkaloid Epimers from Ervatamia yunnanensis Tsiang by pH-Zone-Refining Counter-Current Chromatography Combined with Preparative High-Performance Liquid Chromatography. Molecules. 2019 Apr 3;24(7). pii: molecules24071316. doi: 10.3390/molecules24071316. [PubMed:30987224 ]
- Goswami P, Borah AJ, Phukan P: Formation of Cyclohepta[b]indole Scaffolds via Heck Cyclization: A Strategy for Structural Analogues of Ervatamine Group of Indole Alkaloid. J Org Chem. 2015 Jan 2;80(1):438-46. doi: 10.1021/jo502443a. Epub 2014 Dec 1. [PubMed:25435251 ]
- Fikatas A, Vervaeke P, Meyen E, Llor N, Ordeix S, Boonen I, Bletsa M, Kafetzopoulou LE, Lemey P, Amat M, Pannecouque C, Schols D: A Novel Series of Indole Alkaloid Derivatives Inhibit Dengue and Zika Virus Infection by Interference with the Viral Replication Complex. Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0234920. doi: 10.1128/AAC.02349-20. Epub 2021 Jul 16. [PubMed:34001508 ]
- Nge CE, Chong KW, Thomas NF, Lim SH, Low YY, Kam TS: Ibogan, Aspidosperman, Vincamine, and Bisindole Alkaloids from a Malayan Tabernaemontana corymbosa: Iboga Alkaloids with C-20alpha Substitution. J Nat Prod. 2016 May 27;79(5):1388-99. doi: 10.1021/acs.jnatprod.6b00129. Epub 2016 Apr 14. [PubMed:27077800 ]
- Zhang DB, Yu DG, Sun M, Zhu XX, Yao XJ, Zhou SY, Chen JJ, Gao K: Ervatamines A-I, Anti-inflammatory Monoterpenoid Indole Alkaloids with Diverse Skeletons from Ervatamia hainanensis. J Nat Prod. 2015 Jun 26;78(6):1253-61. doi: 10.1021/acs.jnatprod.5b00051. Epub 2015 May 29. [PubMed:26024020 ]
|
|---|